References
- Robinson LE, Bussiere FI, Le Boucher J, Farges MC, Cynober LA, Field CJ, Amino acid nutrition and immune function in tumour-bearing rats: a comparison of glutamine-, arginine-, and ornithine 2-oxoglutarate-supplemented diets. Clin Sci (Lond) 1999;97:657–69.
- Le Bricon T, Cynober L, Field CJ, Baracos VE. Supplemental nutrition with ornithine alpha-ketoglutarate in rats with cancer-associated cachexia: surgical treatment of the tumor improves efficacy of nutritional support. J Nutr 1995;125:2999–3010.
- Harris AL. Hypoxia—a key regulatory factor in tumour growth. Nat Rev 2002;2:38–47.
- Matsumoto K, Imagawa S, Obara N, Suzuki N, Takahashi S, Nagasawa T, 2-Oxoglutarate downregulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxia-inducible factor-1a and inhibits angiogenesis. J Cell Physiol 2006;209:333–40.
- Matsumoto K, Obara N, Ema M, Horie M, Naka A, Takahashi S, Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model. Cancer Sci 2009;100:1639–47.
- Rzeski W, Turski L, Ikonomidou C. Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 2001;98:6372–7.
- Blagosklonny MV, Darzynkiewicz Z, Halicka HD, Pozarowski P, Demidenko ZN, Barry JJ, Paclitaxel induces primary and postmitotic G1 arrest in human arterial smooth muscle cells. Cell Cycle 2004;3:1050–6.
- Walczak K, Dąbrowski W, Langner E, Zgrajka W, Piłat J, Kocki T, Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells. Scand J Gastroenterol 2011;46:903–12.
- Litchfield JT, Wilcoxon FA. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949;96:99–113.
- Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer 2008;8:967–75.
- Rademakers SE, Span PN, Kaanders JH, Sweep FC, van der Kogel AJ, Bussink J. Molecular aspects of tumour hypoxia. Mol Oncol 2008;2:41–53.
- Tennant DA, Gottlieb E. HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression. J Mol Med 2010;88:839–49.
- Meerana SM, Kumar Katiyar S. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci 2008;13:2191–202.
- Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701–4.
- Alkarain A, Jordan R, Slingerland J. p27 deregulation in breast cancer: prognostic significance and implications for therapy. J Mammary Gland Biol Neoplasia 2004;9:67–80.
- Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 2007;6:6–24.
- Lemons JM, Feng XJ, Bennett BD, Legesse-Miller A, Johnson EL, Raitman I, Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol 2010;8:e1000514.
- Hou Y, Wang L, Ding B, Liu Y, Zhu H, Liu J, Dietary alpha-ketoglutarate supplementation ameliorates intestinal injury in lipopolysaccharide-challenged piglets. Amino Acids 2010;39:555–64.
- Yao K, Yin Y, Li X, Xi P, Wang J, Lei J, Alpha-ketoglutarate inhibits glutamine degradation and enhances protein synthesis in intestinal porcine epithelial cells. Amino Acids 2011; DOI: 10.1007/s00726-011-1060-6. [Epub ahead of print]
- Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005;17:596–603.
- Vaisman N, Arber N. The role of nutrition and chemoprevention in colorectal cancer: from observations to expectations. Best Pract Res Clin Gastroenterol 2002;16:201–17.
- Mukhopadhyay A, Banerjee S, Stafford LJ, Xia CX, Liu M, Aggarwal BB. Curcumin induced suppression of cell proliferation correlates with down regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 2002;21:8852–61.
- Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian HM, Resveratrol blocks interleukin- 1[beta]-induced activation of the nuclear transcription factor NF-[kappa]B, inhibits proliferation, causes S-phase arrest and induces apoptosis of acute myeloid leukemia cells. Blood 2003;102:987–95.